Clinical Trials
18 trialsNCT00005028 2019-11-04
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
University of Maryland, Baltimore
Phase 2 Completed
NCT00006022 2015-12-14
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Virginia Commonwealth University
Phase 1 Completed
NCT00003174 2014-04-24
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00004144 2014-04-24
Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00003936 2014-04-11
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003242 2013-06-24
Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003443 2013-06-24
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00003205 2013-05-30
Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
University of Colorado, Denver
Phase 2 Completed
NCT00002907 2013-04-05
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00002908 2013-04-05
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003171 2013-04-05
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003220 2013-04-05
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00005849 2013-02-11
Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
University of Chicago
Phase 2 Completed
NCT00003132 2012-11-09
Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer
NYU Langone Health
Phase 1 Completed
NCT00136461 2011-03-10
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00017342 2010-03-01
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
Virginia Commonwealth University
Phase 2 Completed
NCT00005580 2010-02-24
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
Virginia Commonwealth University
Phase 1 Completed
NCT00003079 2010-02-17
Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
Virginia Commonwealth University
Phase 1 Completed